In addition to its well-known role in EMT, vimentin was also suggested to have another possible tumor-promoting mechanism in our study: it may induce immunosuppression via the PD-1/PD-L1 axis and inhibit CD8+ T cell function. This evidence concerns the gene CD8A and neoplasm.